These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

449 related items for PubMed ID: 18311458

  • 41. Tumor necrosis factor alpha haplotypes versus tumor necrosis factor alpha -308 G/A polymorphism in the prediction of infliximab treatment efficacy in rheumatoid arthritis.
    Mugnier B, Roudier J.
    Arthritis Rheum; 2004 Dec; 50(12):4075-6; author reply 4076-7. PubMed ID: 15593229
    [No Abstract] [Full Text] [Related]

  • 42. Rituximab in rheumatoid arthritis following anti-TNF-associated tuberculosis.
    Burr ML, Malaviya AP, Gaston JH, Carmichael AJ, Ostör AJ.
    Rheumatology (Oxford); 2008 May; 47(5):738-9. PubMed ID: 18375402
    [No Abstract] [Full Text] [Related]

  • 43. Necrotizing scleritis associated with rheumatoid arthritis: long-term remission with high-dose infliximab therapy.
    Ashok D, Ayliffe WH, Kiely PD.
    Rheumatology (Oxford); 2005 Jul; 44(7):950-1. PubMed ID: 15827040
    [No Abstract] [Full Text] [Related]

  • 44. Infectious complications of biologic agents.
    Martin-Mola E, Balsa A.
    Rheum Dis Clin North Am; 2009 Feb; 35(1):183-99. PubMed ID: 19481004
    [Abstract] [Full Text] [Related]

  • 45. Neurological complications of infliximab.
    Jarand J, Zochodne DW, Martin LO, Voll C.
    J Rheumatol; 2006 May; 33(5):1018-20. PubMed ID: 16511935
    [Abstract] [Full Text] [Related]

  • 46. [Basic therapeutic and immunosuppressive drugs in rheumatoid arthritis. No fear of "heavy weapons"].
    Krüger K.
    MMW Fortschr Med; 2002 Aug 22; 144(33-34):25-30. PubMed ID: 12380140
    [No Abstract] [Full Text] [Related]

  • 47. Tuberculosis following therapy with infliximab may be refractory to antibiotic therapy.
    Taylor JC, Orkin R, Lanham J.
    Rheumatology (Oxford); 2003 Jul 22; 42(7):901-2. PubMed ID: 12826707
    [No Abstract] [Full Text] [Related]

  • 48. Chronic myeloid leukaemia and tuberculosis in a patient with rheumatoid arthritis treated with infliximab.
    Broussais F, Kawashima M, Marotte H, Miossec P.
    Ann Rheum Dis; 2005 Mar 22; 64(3):509-10. PubMed ID: 15708911
    [No Abstract] [Full Text] [Related]

  • 49. Pneumocystis pneumonia associated with infliximab in Japan.
    Harigai M, Koike R, Miyasaka N, Pneumocystis Pneumonia under Anti-Tumor Necrosis Factor Therapy (PAT) Study Group.
    N Engl J Med; 2007 Nov 01; 357(18):1874-6. PubMed ID: 17978303
    [No Abstract] [Full Text] [Related]

  • 50. Severe interstitial pneumonitis associated with infliximab therapy.
    Chatterjee S.
    Scand J Rheumatol; 2004 Nov 01; 33(4):276-7. PubMed ID: 15370726
    [No Abstract] [Full Text] [Related]

  • 51. [TNF-alpha blockers, rheumatoid arthritis and pulmonary tuberculosis].
    Mihăltan F.
    Pneumologia; 2007 Nov 01; 56(4):212-6. PubMed ID: 18320798
    [No Abstract] [Full Text] [Related]

  • 52. An atypical presentation of visceral leishmaniasis infection in a patient with rheumatoid arthritis treated with infliximab.
    Kritikos K, Haritatos E, Tsigkos S, Gounari P, Skrapari I, Gounaris T, Sioula E.
    J Clin Rheumatol; 2010 Jan 01; 16(1):38-9. PubMed ID: 20051756
    [Abstract] [Full Text] [Related]

  • 53. Report of an additional case of anti-tumor necrosis factor therapy and Listeria monocytogenes infection: comment on the letter by Glück et al.
    Aparicio AG, Muñoz-Fernández S, Bonilla G, Miralles A, Cerdeño V, Martín-Mola E.
    Arthritis Rheum; 2003 Jun 01; 48(6):1764-5; author reply 1765-6. PubMed ID: 12794847
    [No Abstract] [Full Text] [Related]

  • 54. Severe refractory rheumatoid arthritis successfully treated with combination rituximab and anti-tumor necrosis factor-alpha-blocking agents.
    Koumakis E, Wipff J, Avouac J, Kahan A, Allanore Y.
    J Rheumatol; 2009 Sep 01; 36(9):2125-6. PubMed ID: 19738227
    [No Abstract] [Full Text] [Related]

  • 55. Interstitial pneumonitis and anti-tumor necrosis factor-alpha therapy.
    Roos JC, Chilvers ER, Ostor AJ.
    J Rheumatol; 2007 Jan 01; 34(1):238-9; author reply 239. PubMed ID: 17216703
    [No Abstract] [Full Text] [Related]

  • 56. [Up-date on the use of infliximab in dermatology. Introduction].
    Sánchez-Carazo J.
    Actas Dermosifiliogr; 2008 Jul 01; 99 Suppl 4():1. PubMed ID: 19080984
    [No Abstract] [Full Text] [Related]

  • 57. Guillain-Barré syndrome in a patient receiving anti-tumour necrosis factor alpha for rheumatoid arthritis: a case report and discussion of literature.
    Silburn S, McIvor E, McEntegart A, Wilson H.
    Ann Rheum Dis; 2008 Apr 01; 67(4):575-6. PubMed ID: 18349168
    [No Abstract] [Full Text] [Related]

  • 58. Comparative overview of safety of the biologics in rheumatoid arthritis.
    Khraishi M.
    J Rheumatol Suppl; 2009 Jun 01; 82():25-32. PubMed ID: 19509327
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.